Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00041561 · ClinicalTrials.gov registry record · Phase 3
Effects of Inhaled Nitric Oxide in the Treatment of Acute Hypoxemic Respiratory Failure (AHRF) in Pediatrics
A Phase 3 study, sponsored by Mallinckrodt.
- Terminated
- Registry status
- Phase 3
- Development phase
- 55
- Enrollment target
NCT00041561 is a Phase 3 study that was terminated before completion, run by Mallinckrodt. The registered enrollment target is 55 participants.
The verdict
NCT00041561, a Phase 3 study, was terminated before completion, sponsored by Mallinckrodt.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 55 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect of nitric oxide for inhalation on the duration of mechanical ventilation in pediatric patients with AHRF.
Interventions
- DRUG Nitrogen gas
- DRUG inhaled nitric oxide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2002-01 |
| Est. Completion | 2004-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00041561
The ClinicalTrials.gov registry entry for NCT00041561 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mallinckrodt, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nitrogen gas is the first listed.
NCT00041561 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00041561 about?
NCT00041561 is a clinical study titled "Effects of Inhaled Nitric Oxide in the Treatment of Acute Hypoxemic Respiratory Failure (AHRF) in Pediatrics". The purpose of this study is to determine the effect of nitric oxide for inhalation on the duration of mechanical ventilation in pediatric patients with AHRF.
What is the current status of trial NCT00041561?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 55 participants. The study started on 2002-01. Estimated completion is 2004-12.
What interventions are being tested in trial NCT00041561?
The interventions under investigation include: Nitrogen gas (DRUG), inhaled nitric oxide (DRUG).
Who is sponsoring clinical trial NCT00041561?
This trial is sponsored by Mallinckrodt, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.